Taita Chemical Company, Limited Profile Avatar - Palmy Investing

Taita Chemical Company, Limited

Taita Chemical Company, Limited produces and sells styrenics in Taiwan, Mainland China, Hong Kong, and the United States. It offers acrylonitrile-butadiene-styrene resin, a terpolymer plastic under the TAITALAC brand; general purpose and high impact poly…

Chemicals - Specialty
TW, Taipei [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q1 Q3 Δ in %
EV/EBITDA -151.85 -207.22 -82.28
Graham Fair Price -4.42 9.49 9.93
PEG -90.30 -0.14 1.47
Price/Book 44.56 1.36 0.94
Price/Cash Flow 27.71 -10.08 -13.94
Prices/Earnings -42.84 -21.70 -15.19
Price/Sales 1.75 1.66 1.63
Price/FCF 27.71 -10.08 -13.94
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q1 Q3 Δ in %
Gross Profit Margin 675.19 0.07 < 0.005
Operating Margin 73.70 -0.01 -0.05
ROA 8.57 -0.01 -0.01
ROE -0.02 -0.02 -1.21
ROIC -0.02 < 0.005 58.72
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q3 Δ in %
Debt QOQ 0.55 0.38 45.86
Dividends QOQ 0.00 1638.47 100.00
EBIT QOQ -0.83 0.30 -63.76
EPS QOQ 0.10 -1.52 1371.95
FCF QOQ -0.06 -3.81 -6207.59
Revenue QOQ -0.07 0.05 -26.41
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q1 Q3 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 24.52 23.49 -4.21
Days Sales Outstanding (DSO) 51.92 0.00 inf
Inventory Turnover 3.67 3.83 4.39
Debt/Capitalization 0.15 0.22 43.32
Quick Ratio 1.97 1.65 -15.90
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q1 Q3 Δ in %
Book Value 16.84 16.00 -4.99
Cash 6.07 5.91 -2.66
Capex -0.12 0.09 -23.14
Free Cash Flow -1.13 -2.15 -89.99
Revenue 9.71 13.10 34.98
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q1 Q3 Δ in %
Current Ratio 2.54 2.05 -19.23
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 12.65 2.27 -82.10
Naive Interpretation Member
06 - Financial Health · Bad
End of 1309.TW's Analysis
CIK: - CUSIP: - ISIN: TW0001309003 LEI: - UEI: -
Secondary Listings
1309.TW has no secondary listings inside our databases.